TrianglePUBLICATIONS · 30351488
Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Cancer
- Publication date
- 2019 Jan 1
- First author
- Bazarbachi A
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Bazarbachi A
- type
- Author
- name
- Boumendil A
- type
- Author
- name
- Finel H
- type
- Author
- name
- Mohty M
- type
- Author
- name
- Castagna L
- type
- Author
- name
- Blaise D
- type
- Author
- name
- Peggs KS
- type
- Author
- name
- Afanasyev B
- type
- Author
- name
- Diez-Martin JL
- type
- Author
- name
- Corradini P
- type
- Author
- name
- Michonneau D
- type
- Author
- name
- Robinson S
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Bazarbachi A
- type
- Author
- name
- Boumendil A
- type
- Author
- name
- Finel H
- type
- Author
- name
- Mohty M
- type
- Author
- name
- Castagna L
- type
- Author
- name
- Blaise D
- type
- Author
- name
- Peggs KS
- type
- Author
- name
- Afanasyev B
- type
- Author
- name
- Diez-Martin JL
- type
- Author
- name
- Corradini P
- type
- Author
- name
- Michonneau D
- type
- Author
- name
- Robinson S
- type
- Author
- bibliography ids
- nci-bib-3f12448af3e01a95d4284f30
- book metadata
- content sha256
- 815c58947f21ceade984eabe643fb95869d9c7c68f40b7508b11c06eee9f5399
- document type
- citation
- dois
- 10.1002/cncr.31755
- electronic publication date
- display
- 2018 Oct 23
- precision
- day
- year
- 2018
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:30351488
- immutable id
- pubmed:30351488@815c58947f21ceade984eabe643fb95869d9c7c68f40b7508b11c06eee9f5399
- journal
- abbreviation
- Cancer
- issn electronic
- 1097-0142
- issn print
- 0008-543X
- issue
- 1
- name
- Cancer
- nlm unique id
- 0374236
- pages
- 90-98
- volume
- 125
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 30351488
- provenance
- batch id
- 438b2803888025c6cf56
- provider
- NCBI PubMed ESummary
- record sha256
- 7586c50b4ef0eff3cba4de460095386a87fcf0b08c4a5829be57f35c6824fb01
- response sha256
- 0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
- retrieved at
- 2026-09-09T23:47:36.359220+00:00
- publication date
- display
- 2019 Jan 1
- precision
- day
- year
- 2019
- publication types
- Journal Article
- Multicenter Study
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party.
Preserved source evidence · Not medical advice